SWOG clinical trial number
CTSU/CALGB 140503
A Phase III Randomized Trial Of Lobectomy Versus Sublobar Resection For Small (Less Than Or Equal To 2 cm) Peripheral Non-Small Cell Lung Cancer
Closed
Abbreviated Title
Phase III Randomized Lobectomy vs Sublobar Resection in Small Peripheral NSCLC
Status Notes
This study is permanently closed for all initial registrations effective Friday, March 13, 2017 at 4:30 p.m. EST.
Activated
01/15/2008
Closed
03/13/2017
Participants
CTSU
Research committees
Lung Cancer
Treatment
Surgery
Eligibility Criteria Expand/Collapse
The Southwest Oncology Group has endorsed this study through the Cancer Trials Support Unit (CTSU) of the National Cancer Institute.
Please contact the CTSU directly by either phone (1-888-823-5923) or on the CTSU web site (http://www.ctsu.org/) for more information and registration procedures.
Please contact the CTSU directly by either phone (1-888-823-5923) or on the CTSU web site (http://www.ctsu.org/) for more information and registration procedures.
Other Clinical Trials
SWOG Clinical Trial Number
A082002
A Randomized Phase II/III Trial of Modern Immunotherapy Based Systemic Therapy with or Without SBRT for PD-L1-Negative, Advanced Non-Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
12/21/2021
Open
Phase
SWOG Clinical Trial Number
CTSU/NRG-LU007
RAndomized Phase II/III Trial Of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial
Research Committee(s)
Lung Cancer
Activated
08/17/2020
Open
SWOG Clinical Trial Number
CTSU/A081801
Integration of Immunotherapy into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO
Research Committee(s)
Lung Cancer
Activated
06/23/2020
Open
Phase